Using Onco4D test to guide chemotherapy choices
Part of Cancer clinical trials.
This study looks at how a special test called Onco4D helps doctors choose the right chemotherapy for people with cancer. The study tracks your cancer treatment and outcomes to see if the test improves results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have any type of cancer confirmed by a biopsy or tissue sample.
- Your doctor has ordered the Onco4D test to help choose chemotherapy.
- You are willing to sign a consent form to participate.
- You are 18 years old or older.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how doing genetic (DNA) testing on your cancer helps doctors choose targeted treatments, and how those treatments affect outcomes. It is for adults whose cancer has not responded to the first standard treatment or who do not have curative options.
This British Columbia study looks at how well different cancer treatments work in real life when doctors aren't sure which option is best. You and your doctor would choose a treatment, and researchers will track your results to help others.
This trial tests whether using advanced genetic testing (called OncoTreat and OncoTarget) can help guide radiation treatment for people whose cancer has spread. The goal is to see if tailoring treatment to your cancer's unique genetics makes radiation more effective.
This study tests whether a special blood test (looking for cancer DNA) can help doctors decide if you need chemotherapy after colorectal cancer surgery. The goal is to avoid unnecessary chemotherapy while making sure patients who need it get treated.
This study tests whether using the Oncogramme® device to guide the first-line treatment improves care for people with metastatic colorectal (colon/rectum) cancer. If the device helps pick the most suitable standard chemotherapy plan, it could lead to better outcomes than choosing without it.
This trial tests whether a blood test for ctDNA (cancer DNA fragments) can help doctors decide if standard chemotherapy plus an immunotherapy drug is working for people with advanced or recurrent endometrial cancer. It may help tailor your treatment based on how the cancer responds.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.